Form D · Biotechnology
INTEGENE INTERNATIONAL HOLDINGS, LLC
Miami, FL · CIK 0001616756
Offering snapshot reported Aug 25, 2014 · SEC filing
- Reported sold
- $300K Offering amount: $350K
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 30, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 25, 2014 | Initial | $300,000 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $27K
- Finders' fees
- $0
- Form D file number
- 021-223539
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Dawson James Securities Inc. | 130645 |
Source: Form D, filed Aug 25, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Gold | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1951 Nw 7 Th Ave Ste. 300
Miami, FL, 33136
Miami, FL, 33136